Tiletamine Hydrochloride + Zolazepam Hydrochloride

21 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

5710.0%

Death Rate

Active Ingredients

Tiletamine HydrochlorideZolazepam Hydrochloride

Administration Routes

IntramuscularIntravenousUnknownSubcutaneous

Species Affected

Dog 10

Cat 10

Deer 1

Most Affected Breeds

Unknown 11

Domestic Shorthair 2

Retriever - Labrador 1

Boxer (German Boxer) 1

Cat (other) 1

Deer (other) 1

Spitz - American Eskimo Dog 1

Terrier - Toy Fox 1

Shepherd Dog - German 1

Siberian Husky 1

Most Reported Reactions

Death 8

Partial lack of efficacy 6

Lack of efficacy - NOS 4

Death by euthanasia 4

Cyanosis 2

Cardiac arrest 2

Unresponsive to stimuli 2

Shaking 2

Recovery prolonged 1

Drug administration error 1

Contamination, Particulate Matter 1

Head tremor 1

Outcome Breakdown

Recovered/Normal

8 (38.1%)

Died

8 (38.1%)

Euthanized

4 (19.0%)

Outcome Unknown

1 (4.8%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.